| + |
IL22RA2 | up-regulates 
binding
|
IL22 |
0.737 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-86113 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 11390453 |
Il-22 mediates inflammation and binds class ii cytokine receptor heterodimers il-22 ra1/crf2-4. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
IL22 | up-regulates
binding
|
IL22RA1 |
0.89 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-86340 |
|
|
Homo sapiens |
T-lymphocyte, Monocyte |
| pmid |
sentence |
| 12941475 |
In addition, il-22 mediates inflammation and binds class ii cytokine receptor heterodimers il-22 ra1/crf2-4. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
IL22 | down-regulates 
binding
|
IL22RA2 |
0.737 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-86110 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 11390453 |
We identified a gene encoding a protein of 231 aa, showing 33 and 34% amino acid identity with the extracellular domains of the il-22 receptor and of the il-20r/cytokine receptor family 2-8,the recombinant protein was found to bind il-10-related t cell-derived inducible factor/il-22, and to inhibit the activity of this cytokine on hepatocytes and intestinal epithelial cells. We propose to name this natural cytokine antagonist il-22bp for il-22 binding protein. respectively, but lacking the transmembrane and cytoplasmic domains |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| Tissue: |
Lung, Breast |
| + |
IL22 | up-regulates
binding
|
IL10RB |
0.684 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-151880 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 17208301 |
See table 2 |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
3.0
IL22
- 
- 